White House drug pricing deals could save $529 billion
The 'most favored nation' drug pricing model introduced by the Trump administration encompasses 17 pharmaceutical firms and is applicable to all markets in the U.S., including those with private insurance. According to the administration, these agreements have the potential to generate savings of $529 billion over a decade.
Key facts
- The Trump administration's 'most favored nation' framework covers 17 pharma companies.
- The framework applies across all U.S. markets, including private insurance.
- The deals could save $529 billion over 10 years.
Entities
Institutions
- White House
Locations
- United States
Sources
- Quartz —